Food Entrepreneur SACRAMENTO, CALIF.  — Biotechnology company One Bio has raised $27 million in a Series A funding round led by Alpha Edison. The round also had such new investors as DSM-Firmenich, Leaps by Bayer, Mitsui E12, Morado, ReMy and Better and existing investors including iSelect, Skyview Life Sciences, Collaborative and Acre. The funding will help the company scale its technology for use in food and beverage to reduce the intake of sugar, eliminate barriers to fiber consumption and help lower metabolic disorders, according to the company.

One Bio said its technology may release anti-inflammatory short-chain fibers from plants. The process also may unlock fibers from seeds, nuts, fruits, vegetables, legumes and grains.

The company’s “Glycopedia,” its catalog of plant carbohydrate structures or plant fiber compositions, enables the company to select plant fiber sources for applications based on chemical structure.

“Modern food processing techniques strip plant fibers from our foods and starve the microbiome of the nutrients it needs to make us healthy,” said Matt Barnard, co-founder and chief executive officer of One Bio. “One Bio works to help us restore core functionality to our diet like blood glucose regulation and mood and energy balance. We aim to avoid and reverse the negative impact of today’s processed food diet, which accounts for 70% of calories consumed. We have the opportunity to offer industry and people an exponentially better set of choices than those on shelves today. One Bio puts thriving microbiomes to work delivering longevity, aiding digestion and providing the fuel we need to maximize health.” 


Enjoying this content? Learn about more disruptive startups on the Food Entrepreneur page.